ATON PORTAGE BIOTECH INC.

Nasdaq portagebiotech.com


$ 2.72 $ 0.09 (3.42 %)    

Friday, 21-Nov-2025 09:47:56 EST
QQQ $ 584.42 $ -2.91 (-0.5 %)
DIA $ 459.85 $ 0.24 (0.05 %)
SPY $ 653.89 $ -1.22 (-0.19 %)
TLT $ 89.40 $ -0.26 (-0.29 %)
GLD $ 374.06 $ 0.07 (0.02 %)
$ 2.68
$ 2.63
$ 2.63 x 10
$ 2.71 x 86
$ 2.62 - $ 2.72
$ 2.65 - $ 15.82
45,209
na
6.11M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON) ("AlphaTON" or the "Company"), a specialized digital asset technology comp...

Core News & Articles

AlphaTON Capital Corp. (NASDAQ:ATON), a leading digital asset company focused on growing the Telegram ecosystem, today announce...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON) – AlphaTON Capital, a leading investm...

Core News & Articles

AlphaTON Capital Corp ("AlphaTON Capital" or the "Company") (NASDAQ:ATON), a specialized digital asset treasury...

Core News & Articles

AlphaTON Capital (NASDAQ:ATON), a leading digital asset infrastructure company focused on Telegram and the TON blockchain ecosy...

Core News & Articles

AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyn...

Core News & Articles

Telegram's more than 1 billion monthly active users represent the world's largest untapped market for AI agents that ac...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION